A brightening active. The maker links it to evening tone and UV protection; independent data are limited. Well tolerated.
Topical application
BLimited evidence. One RCT or several controlled studies with limitations.
A brightening active. Well tolerated; independent data limited.
Dihydroxy Methylchromonyl Palmitate is a chromone derivative esterified with palmitate, found in brightening cosmetics. The INCI matches the name. It is positioned as an active for evening out tone and reducing dullness. On efficacy the enthusiasm needs measuring. The maker links it with a more even tone and some defence against UV stress, but independent data are thin. The sensible read is to treat it as a supporting component alongside better-studied brighteners, not a headline act that replaces niacinamide, vitamin C or azelaic acid. For pregnancy and breastfeeding there are no warning signals for topical use. Systemic exposure is minimal, so it can be used. Tolerance is good. Irritation potential and allergy risk are low, which makes it suitable for sensitive skin. As with any new active, introduce it gradually.
Irritation potential
LowAllergen risk
LowPregnancy
SafeSuitable for
The Evigrade extension adds an evidence panel to iHerb, Sephora, Druni and 12 more stores. This ingredient and every other one in the product show evidence-tier, allergen risk and pregnancy/lactation flags at a glance.
Dihydroxy Methylchromonyl Palmitate is considered safe during pregnancy at typical cosmetic concentrations. Systemic absorption through the skin is minimal.
Dihydroxy Methylchromonyl Palmitate suits: normal, dry, combination, oily, sensitive.
A brightening active.
The INCI name is Dihydroxy Methylchromonyl Palmitate. It may also appear as: Дигидрокси метилхромонил пальмитат, Chromabright.
Published: · updated: